Bruce D R, Odom R B
Cutis. 1986 Nov;38(5):323-4.
We report a case of fixed drug eruption secondary to sulindac (Clinoril). Owing to the drug's current popularity we believe that physicians should be made aware of this phenomenon. We present a patient who had the unusual feature of hypopigmentation associated with healing of his lesion. A brief review of clinical features and pathophysiology of fixed drug eruption is also presented.
我们报告一例因舒林酸（奇诺力）引起的固定性药疹。鉴于该药目前的广泛使用，我们认为应让医生了解这一现象。我们展示了一位患者，其皮损愈合时伴有色素减退这一不寻常特征。本文还简要回顾了固定性药疹的临床特征及病理生理学。
